All data are based on the daily closing price as of July 17, 2024
b

BioPlus

099430.KQ
4.49 USD
-0.04
-0.88%

Overview

Last close
4.49 usd
Market cap
260.25M usd
52 week high
6.56 usd
52 week low
3.15 usd
Target price
6.89 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
6.0855
Price/Book Value
2.9977
Enterprise Value
233.25M usd
EV/Revenue
4.9296
EV/EBITDA
9.0855

Key financials

Revenue TTM
45.18M usd
Gross Profit TTM
N/A usd
EBITDA TTM
20.03M usd
Earnings per Share
N/A usd
Dividend
0.05 usd
Total assets
134.45M usd
Net debt
N/A usd

About

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus " Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; Slim Slimmer, a lipolysis solution; LumiDew, a whitening solution; JuveniHill, an anti-wrinkle solution; and hair scalp care, hair treatment, hair nutrition solutions under the BelloHa and BellaChe names, as well as cosmetics comprising heparinoid essence, EGF ball, and skin care gel under the La Bella name. The company was founded in 2003 and is based in Seongnam-si, South Korea.
  • Symbol
    099430.KQ
  • Exchange
    KQ
  • Isin
    N/A
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Instruments & Supplies
  • CEO
  • Headquarter
    Seongnam-si
  • Web site
    https://www.ubioplus.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top